Adagio Medical Holdings, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
ADGM Nasdaq 3841 adagiomedical.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adagio Medical Holdings, Inc.

Adagio Medical (ADGM) Announces Successful Results From US Cardiac Ablation Feasibility Study - Feb 24th, 2026 11:11 am
Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference - Feb 20th, 2026 6:00 am
Small Cap Growth Virtual Investor Conference: Presentations Now Available for On-Demand Viewing - Feb 6th, 2026 6:35 am
New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia - Feb 4th, 2026 6:00 am
Small Cap Growth Virtual Investor Conference Agenda Announced for February 5th - Feb 2nd, 2026 6:35 am
Adagio Medical to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Feb 2nd, 2026 6:05 am
Adagio Medical to Present at the Small Cap Growth Virtual Investor Conference February 5th - Jan 30th, 2026 6:35 am
Positive Signs As Multiple Insiders Buy Adagio Medical Holdings Stock - Jan 20th, 2026 3:41 am
Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness - Dec 22nd, 2025 6:00 am
Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors - Dec 11th, 2025 6:00 am
Adagio Medical Reports Third Quarter 2025 Results - Nov 12th, 2025 2:05 pm
Adagio Medical to Present at the Piper Sandler 37th Annual Healthcare Conference - Nov 5th, 2025 6:00 am
Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia - Oct 20th, 2025 6:00 am
Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities - Oct 15th, 2025 6:00 am
Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium - Oct 10th, 2025 1:40 pm
Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia - Oct 1st, 2025 6:00 am
Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium - Sep 18th, 2025 6:00 am
Adagio Medical Expands Chief Business Officer Deborah Kaster’s Role to Include Chief Financial Officer Responsibilities - Sep 8th, 2025 6:00 am
Adagio Medical Reports Second Quarter 2025 Results - Aug 13th, 2025 2:30 pm
Adagio Medical Reports First Quarter 2025 Results - May 15th, 2025 2:05 pm